Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosylhomocysteinase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | matrix metalloproteinase | 0.0241 | 0.2582 | 0.197 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0156 | 0.1441 | 0.0991 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0792 | 1 | 1 |
Echinococcus multilocularis | adenosylhomocysteinase | 0.0156 | 0.1441 | 0.0408 |
Brugia malayi | Trypsin family protein | 0.0278 | 0.3079 | 0.2621 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0278 | 0.3079 | 0.3019 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.2582 | 0.197 |
Plasmodium vivax | adenosylhomocysteinase(S-adenosyl-L-homocystein e hydrolase), putative | 0.0156 | 0.1441 | 0.5 |
Leishmania major | S-adenosylhomocysteine hydrolase | 0.0156 | 0.1441 | 0.5 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0697 | 0.8717 | 0.8562 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0241 | 0.2582 | 0.2403 |
Schistosoma mansoni | growth factor receptor-bound protein | 0.0129 | 0.1077 | 0.054 |
Schistosoma mansoni | hypothetical protein | 0.0258 | 0.2811 | 0.2688 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0169 | 0.1614 | 0.1205 |
Toxoplasma gondii | adenosylhomocysteinase, putative | 0.0156 | 0.1441 | 0.5 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0697 | 0.8717 | 1 |
Brugia malayi | Adenosylhomocysteinase | 0.0156 | 0.1441 | 0.0477 |
Trypanosoma brucei | S-adenosylhomocysteine hydrolase, putative | 0.0156 | 0.1441 | 0.5 |
Onchocerca volvulus | 0.0278 | 0.3079 | 0.126 | |
Loa Loa (eye worm) | matrixin family protein | 0.0499 | 0.6053 | 0.6513 |
Onchocerca volvulus | 0.0258 | 0.2811 | 0.0582 | |
Loa Loa (eye worm) | adenosylhomocysteinase | 0.0156 | 0.1441 | 0.0477 |
Toxoplasma gondii | S-Adenosyl homocysteine hydrolase | 0.0156 | 0.1441 | 0.5 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0293 | 0.3288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0293 | 0.3288 | 0.2894 |
Loa Loa (eye worm) | matrixin family protein | 0.0534 | 0.6529 | 0.7136 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.2582 | 0.197 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.0156 | 0.1441 | 0.5 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0293 | 0.3288 | 0.2894 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0697 | 0.8717 | 0.8562 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0697 | 0.8717 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0534 | 0.6529 | 1 |
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0697 | 0.8717 | 1 |
Mycobacterium ulcerans | hydrolase | 0.0293 | 0.3288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.2582 | 0.197 |
Schistosoma mansoni | growth factor receptor-bound protein | 0.0129 | 0.1077 | 0.054 |
Brugia malayi | Matrixin family protein | 0.0241 | 0.2582 | 0.197 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.0156 | 0.1441 | 1 |
Brugia malayi | Hemopexin family protein | 0.0258 | 0.2811 | 0.227 |
Onchocerca volvulus | Matrilysin homolog | 0.0534 | 0.6529 | 1 |
Entamoeba histolytica | adenosylhomocysteinase, putative | 0.0156 | 0.1441 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0278 | 0.3079 | 0.2621 |
Brugia malayi | Matrixin family protein | 0.0241 | 0.2582 | 0.197 |
Echinococcus granulosus | adenosylhomocysteinase | 0.0156 | 0.1441 | 0.0408 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0293 | 0.3288 | 1 |
Onchocerca volvulus | 0.0257 | 0.2798 | 0.0547 | |
Brugia malayi | Matrixin family protein | 0.0241 | 0.2582 | 0.197 |
Brugia malayi | Matrixin family protein | 0.0499 | 0.6053 | 0.6513 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.0156 | 0.1441 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0278 | 0.3079 | 0.2621 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.0156 | 0.1441 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0278 | 0.3079 | 0.3019 |
Plasmodium falciparum | adenosylhomocysteinase | 0.0156 | 0.1441 | 0.5 |
Brugia malayi | Matrixin family protein | 0.0241 | 0.2582 | 0.197 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 32.2 % | Induction of apoptosis in human MCF7 cells assessed as viable cells at 15 uM after 48 hrs by AnnexinV-FITC staining based flow cytometry (Rvb = 74.4 +/- 9.1 %) | ChEMBL. | No reference |
ED50 (functional) | = 0.24 ug ml-1 | In vitro anti-vesicular stomatitis virus activity of the compound was determined in vero cell cultures | ChEMBL. | No reference |
IC50 (functional) | = 0.55 ug ml-1 | Cytotoxic effect of the compound on host cells during growth phase of virus in vero cell cultures using MTT method | ChEMBL. | No reference |
IC50 (functional) | > 500 ug ml-1 | Cytotoxic effect of the compound on host cells during stationary phase of virus in vero cell cultures using MTT method | ChEMBL. | No reference |
IC50 (binding) | = 0.44 uM | Inhibition of recombinant human placental AdoHcy hydrolase expressed in Escherichia coli BL21 using AdoHcy as substrate preincubated for 10 mins followed by substrate addition measured after 20 mins by DTNB coupled assay | ChEMBL. | 26010585 |
IC50 (functional) | = 1.4 uM | Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by sulforhodamine B assay | ChEMBL. | 26010585 |
Selectivity index (functional) | = 2.3 | Ratio of cytotoxicity, IC50(growing) to antiviral activity (ED50) of the compound was determined | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 26010585 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.